Fibrocell Science (FCSC) – Management Comments
-
Fibrocell Science (FCSC) to be Acquired by Castle Creek Pharma for $3/Share
-
Fibrocell Science (FCSC) Granted FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for Treatment of RDEB
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to FCSC Stock Lookup